NYSE - Nasdaq Real Time Price USD

Ameresco, Inc. (AMRC)

21.97 +0.99 (+4.72%)
As of 11:25 AM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 10101210
Avg. Estimate -0.110.291.392.02
Low Estimate -0.230.151.291.51
High Estimate -0.030.391.512.45
Year Ago EPS 0.030.151.261.39

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 11111311
Avg. Estimate 255.43M390.01M1.63B1.84B
Low Estimate 237.68M345.8M1.56B1.73B
High Estimate 275M451.4M1.7B1.97B
Year Ago Sales 271.04M327.07M1.37B1.63B
Sales Growth (year/est) -5.80%19.20%18.60%13.10%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.030.180.460.57
EPS Actual 0.030.150.40.69
Difference 0-0.03-0.060.12
Surprise % 0.00%-16.70%-13.00%21.10%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.110.291.392.02
7 Days Ago -0.10.281.42.01
30 Days Ago -0.10.291.42.03
60 Days Ago 0.220.41.812.52
90 Days Ago 0.240.41.852.5

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days ----1--
Up Last 30 Days ----1--
Down Last 7 Days --------
Down Last 30 Days 11--1

Growth Estimates

CURRENCY IN USD AMRCIndustrySectorS&P 500
Current Qtr. -466.70%----1.50%
Next Qtr. 93.30%----12.10%
Current Year 10.30%----4.40%
Next Year 45.30%----13.20%
Next 5 Years (per annum) 27.20%----10.97%
Past 5 Years (per annum) 15.20%------

Research Analysis

Analyst Price Targets

28.00
36.73 Average
21.97 Current
54.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Truist Securities: Buy to Buy 4/22/2024
Maintains Oppenheimer: Perform to Perform 4/17/2024
Maintains Piper Sandler: Overweight to Overweight 4/11/2024
Maintains Raymond James: Outperform to Outperform 4/3/2024
Upgrade Exane BNP Paribas: Neutral to Outperform 3/12/2024
Maintains Piper Sandler: Overweight to Overweight 3/5/2024

Related Tickers